메뉴 건너뛰기




Volumn 14, Issue 10, 2018, Pages e602-e609

Use of patient-reported outcome measures in quality oncology practice initiative-registered practices: Results of a national survey

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DISTRESS SYNDROME; ELECTRONIC HEALTH RECORD; HEALTH CARE SYSTEM; HUMAN; MALIGNANT NEOPLASM; PATIENT ATTITUDE; PATIENT DECISION MAKING; PATIENT SATISFACTION; PATIENT-REPORTED OUTCOME; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; NEOPLASM; ONCOLOGY;

EID: 85054888633     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.18.00088     Document Type: Article
Times cited : (26)

References (14)
  • 1
    • 42749098792 scopus 로고    scopus 로고
    • Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance
    • US Department of Health and Human Services FDA Center for Drug Evaluation and Research; US Department of Health and Human Services FDA Center for Biologics Evaluation and Research; US Department of Health and Human Services FDA Center for Devices and Radiological Health
    • US Department of Health and Human Services FDA Center for Drug Evaluation and Research; US Department of Health and Human Services FDA Center for Biologics Evaluation and Research; US Department of Health and Human Services FDA Center for Devices and Radiological Health: Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4: 79, 2006
    • (2006) Health Qual Life Outcomes , vol.4 , pp. 79
  • 2
    • 84871916353 scopus 로고    scopus 로고
    • Patient-reported outcomes (PROs): The significance of using humanistic measures in clinical trial and clinical practice
    • Refolo P, Minacori R, Mele V, et al: Patient-reported outcomes (PROs): The significance of using humanistic measures in clinical trial and clinical practice. Eur Rev Med Pharmacol Sci 16: 1319-1323, 2012
    • (2012) Eur Rev Med Pharmacol Sci , vol.16 , pp. 1319-1323
    • Refolo, P.1    Minacori, R.2    Mele, V.3
  • 3
    • 1442283184 scopus 로고    scopus 로고
    • Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial
    • Velikova G, Booth L, Smith AB, et al: Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial. J Clin Oncol 22: 714-724, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 714-724
    • Velikova, G.1    Booth, L.2    Smith, A.B.3
  • 4
    • 39149101458 scopus 로고    scopus 로고
    • The impact of measuring patientreported outcomes in clinical practice: A systematic review of the literature
    • Valderas JM, Kotzeva A, Espallargues M, et al: The impact of measuring patientreported outcomes in clinical practice: A systematic review of the literature. Qual Life Res 17: 179-193, 2008
    • (2008) Qual Life Res , vol.17 , pp. 179-193
    • Valderas, J.M.1    Kotzeva, A.2    Espallargues, M.3
  • 5
    • 84902820334 scopus 로고    scopus 로고
    • What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials
    • Kotronoulas G, Kearney N, Maguire R, et al: What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32: 1480-1501, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 1480-1501
    • Kotronoulas, G.1    Kearney, N.2    Maguire, R.3
  • 6
    • 85020425017 scopus 로고    scopus 로고
    • Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    • Basch E, Deal AM, Dueck AC, et al: Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318: 197-198, 2017
    • (2017) JAMA , vol.318 , pp. 197-198
    • Basch, E.1    Deal, A.M.2    Dueck, A.C.3
  • 7
    • 84964265718 scopus 로고    scopus 로고
    • Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial
    • Basch E, Deal AM, Kris MG, et al: Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol 34: 557-565, 2016
    • (2016) J Clin Oncol , vol.34 , pp. 557-565
    • Basch, E.1    Deal, A.M.2    Kris, M.G.3
  • 8
    • 84880166205 scopus 로고    scopus 로고
    • Standards for patient-reported outcome-based performance measures
    • Basch E, Torda P, Adams K: Standards for patient-reported outcome-based performance measures. JAMA 310: 139-140, 2013
    • (2013) JAMA , vol.310 , pp. 139-140
    • Basch, E.1    Torda, P.2    Adams, K.3
  • 9
    • 85055876170 scopus 로고    scopus 로고
    • ASCO PRO workgroup update: Patientreported outcome measures as a quality indicator
    • Stover AM CA, Basch EM: ASCO PRO workgroup update: Patientreported outcome measures as a quality indicator. J Clin Oncol 34: 276, 2016 (7-suppl)
    • (2016) J Clin Oncol , vol.34 , Issue.7 , pp. 276
    • Stover, A.M.C.A.1    Basch, E.M.2
  • 12
    • 85030756166 scopus 로고    scopus 로고
    • Implementing patient-reported outcome surveys as part of routine care: Lessons from an academic radiation oncology department
    • Rotenstein LS, Agarwal A, O'Neil K, et al: Implementing patient-reported outcome surveys as part of routine care: Lessons from an academic radiation oncology department. J Am Med Inform Assoc 24: 964-968, 2017
    • (2017) J Am Med Inform Assoc , vol.24 , pp. 964-968
    • Rotenstein, L.S.1    Agarwal, A.2    O'Neil, K.3
  • 13
    • 85027891035 scopus 로고    scopus 로고
    • Feasibility assessment of patient reporting of symptomatic adverse events in multicenter cancer clinical trials
    • Basch E, Dueck AC, Rogak LJ, et al: Feasibility assessment of patient reporting of symptomatic adverse events in multicenter cancer clinical trials. JAMA Oncol 3: 1043-1050, 2017
    • (2017) JAMA Oncol , vol.3 , pp. 1043-1050
    • Basch, E.1    Dueck, A.C.2    Rogak, L.J.3
  • 14
    • 84961912420 scopus 로고    scopus 로고
    • Methods for implementing and reporting patientreported outcome (PRO) measures of symptomatic adverse events in cancer clinical trials
    • Basch E, Rogak LJ, Dueck AC: Methods for implementing and reporting patientreported outcome (PRO) measures of symptomatic adverse events in cancer clinical trials. Clin Ther 38: 821-830, 2016
    • (2016) Clin Ther , vol.38 , pp. 821-830
    • Basch, E.1    Rogak, L.J.2    Dueck, A.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.